COVID-19: Herd immunity and convalescent plasma transfer therapy.
作者信息
Syal Kirtimaan
机构信息
Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, Memphis, Tennessee.
Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin.
出版信息
J Med Virol. 2020 Sep;92(9):1380-1382. doi: 10.1002/jmv.25870. Epub 2020 Jul 11.
Abstract
摘要
相似文献
1
COVID-19: Herd immunity and convalescent plasma transfer therapy.新型冠状病毒肺炎：群体免疫与恢复期血浆输注疗法
J Med Virol. 2020 Sep;92(9):1380-1382. doi: 10.1002/jmv.25870. Epub 2020 Jul 11.
2
Convalescent plasma to treat COVID-19: Following the Argentinian lead.用康复期血浆治疗新冠肺炎：效仿阿根廷的做法。
Transfus Apher Sci. 2021 Jun;60(3):103161. doi: 10.1016/j.transci.2021.103161. Epub 2021 May 23.
3
Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.恢复期血浆治疗 COVID-19：美国国立卫生研究院 COVID-19 治疗指南专家组的观点。
Ann Intern Med. 2021 Jan;174(1):93-95. doi: 10.7326/M20-6448. Epub 2020 Sep 25.
4
Fast-spreading COVID variant can elude immune responses.快速传播的新冠病毒变种能够逃避免疫反应。
Nature. 2021 Jan;589(7843):500-501. doi: 10.1038/d41586-021-00121-z.
5
Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy.谷歌趋势显示了公众对新冠康复者血浆疗法的兴趣。
J Clin Apher. 2021 Jun;36(3):492-493. doi: 10.1002/jca.21862. Epub 2020 Dec 19.
6
Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.新冠康复者血浆捐献及治疗新冠患者的年龄上限：年龄歧视的又一标志。
Transfusion. 2021 Sep;61(9):2799-2800. doi: 10.1111/trf.16581. Epub 2021 Jul 5.
7
Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report.新型冠状病毒肺炎康复者血浆可提高重症监护病房生存率。初步报告。
Transfus Apher Sci. 2020 Oct;59(5):102848. doi: 10.1016/j.transci.2020.102848. Epub 2020 Jun 10.
8
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies.对体液免疫受损且缺乏中和抗体的淋巴瘤患者，采用恢复期血浆治疗持续性严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染
Br J Haematol. 2021 Mar;192(6):1100-1105. doi: 10.1111/bjh.17266. Epub 2020 Dec 13.
9
A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: A case report.1例新型冠状病毒肺炎伴细胞因子风暴患者，先后连续采用治疗性血浆置换和恢复期血浆输注治疗：病例报告
J Med Virol. 2021 Apr;93(4):1854-1856. doi: 10.1002/jmv.26630. Epub 2020 Nov 10.
10
Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.恢复期血浆疗法：一种针对侵袭性新冠病毒病的被动疗法。
J Med Virol. 2020 Nov;92(11):2251-2253. doi: 10.1002/jmv.26047. Epub 2020 Jun 9.
引用本文的文献
1
Impact of a New SARS-CoV-2 Variant on the Population: A Mathematical Modeling Approach.一种新型严重急性呼吸综合征冠状病毒2变体对人群的影响：一种数学建模方法。
Math Comput Appl. 2021 Jun;26(2). doi: 10.3390/mca26020025. Epub 2021 Mar 27.
2
Epidemiology of COVID-19.新型冠状病毒肺炎流行病学
J Dig Endosc. 2020 Mar;11(1):3-7. doi: 10.1055/s-0040-1712187.
3
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019.2019冠状病毒病恢复期血浆治疗的进展与挑战
Infect Dis Immun. 2021 Apr 20;1(1):52-58. doi: 10.1097/01.ID9.0000733568.58627.47. eCollection 2021 Apr.
4
Modelling the impact of plasma therapy and immunotherapy for recovery of COVID-19 infected individuals.模拟血浆疗法和免疫疗法对新冠病毒感染患者康复的影响。
Sao Paulo J Math Sci. 2021;15(1):344-364. doi: 10.1007/s40863-021-00232-5. Epub 2021 Apr 12.
5
Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19.新型冠状病毒肺炎患者恢复期血浆输注的临床护理方案
Int J Afr Nurs Sci. 2023;18:100518. doi: 10.1016/j.ijans.2022.100518. Epub 2022 Dec 13.
6
Threshold conditions for global stability of disease free state of COVID-19.新型冠状病毒肺炎无病状态全局稳定性的阈值条件
Results Phys. 2021 Feb;21:103784. doi: 10.1016/j.rinp.2020.103784. Epub 2021 Jan 6.
7
Mathematical modeling to study the impact of immigration on the dynamics of the COVID-19 pandemic: A case study for Venezuela.运用数学模型研究移民对 COVID-19 大流行动态的影响：以委内瑞拉为例。
Spat Spatiotemporal Epidemiol. 2022 Nov;43:100532. doi: 10.1016/j.sste.2022.100532. Epub 2022 Aug 28.
8
A Review on Effectiveness of Plasma Therapy in Severe COVID-19 Patients.重症新型冠状病毒肺炎患者血浆疗法有效性综述
Cureus. 2022 Sep 7;14(9):e28914. doi: 10.7759/cureus.28914. eCollection 2022 Sep.
9
An Unusual Presentation of Superior Mesenteric Venous Occlusion in Mild COVID-19.轻度新型冠状病毒肺炎中肠系膜上静脉闭塞的罕见表现
Indian J Clin Biochem. 2023 Apr;38(2):275-278. doi: 10.1007/s12291-022-01067-3. Epub 2022 Aug 10.
10
Vitamin C and its therapeutic potential in the management of COVID19.维生素 C 及其在 COVID19 治疗中的潜在作用。
Clin Nutr ESPEN. 2022 Aug;50:8-14. doi: 10.1016/j.clnesp.2022.05.026. Epub 2022 Jun 4.
本文引用的文献
1
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.新冠病毒核酸检测复阳康复患者的临床特征
Ann Transl Med. 2020 Sep;8(17):1084. doi: 10.21037/atm-20-5602.
2
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
3
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
4
Potential therapeutic agents against COVID-19: What we know so far.针对 COVID-19 的潜在治疗药物：目前我们所了解的情况。
J Chin Med Assoc. 2020 Jun;83(6):534-536. doi: 10.1097/JCMA.0000000000000318.
5
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.对于重症新冠病毒感染患者，没有证据表明羟氯喹和阿奇霉素联合使用能实现快速的抗病毒清除或带来临床益处。
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.
6
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.康复血浆治疗新冠病毒病：可能性与挑战
JAMA. 2020 Apr 28;323(16):1561-1562. doi: 10.1001/jama.2020.4940.
7
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
8
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病（COVID-19）疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
9
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
10
Understanding of COVID-19 based on current evidence.基于现有证据对 COVID-19 的理解。
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.
Zotero 插件